English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [843]
News [2102]
Articles [21]
Editorials [1]
Conferences [129]
elearning [2]
Denosumab improves disease-free survival for postmenopausal HR-positive breast...
Prof Michael Gnant - Medical University of Vienna, Vienna, Austria
Denosumab improves disease-free survival for postmenopausal HR-positive breast cancer ( Prof Michael Gnant - Medical University of Vienna, Vienna, Austria )
9 Dec 2015
Women with luminal A subtype of breast cancer did not benefit from adjuvant...
Dr Torsten Nielsen - University of British Columbia, Vancouver, Canada
Women with luminal A subtype of breast cancer did not benefit from adjuvant chemotherapy ( Dr Torsten Nielsen - University of British Columbia, Vancouver, Canada )
9 Dec 2015
Pathologic complete response to presurgery chemo improves survival for triple...
Dr William Sikov - Women & Infants Hospital of Rhode Island, Providence, USA
Pathologic complete response to presurgery chemo improves survival for triple-negative breast cancer ( Dr William Sikov - Women & Infants Hospital of Rhode Island, Providence, USA )
9 Dec 2015
ASH 2015: Highlights in mantle cell lymphoma
Prof Simon Rule and Prof Steven Le Gouill
ASH 2015: Highlights in mantle cell lymphoma ( Prof Simon Rule and Prof Steven Le Gouill )
7 Dec 2015
ASH 2015: Novel combination approaches for multiple myeloma
Prof Marivi Mateos, Prof Sagar Lonial, Dr Torben Plesner, Prof Meletios...
ASH 2015: Novel combination approaches for multiple myeloma ( Prof Marivi Mateos, Prof Sagar Lonial, Dr Torben Plesner, Prof Meletios Dimopoulos )
6 Dec 2015
ASH 2015: Ibrutinib as first-line treatment for chronic lymphocytic leukaemia
Prof John Gribben and Prof Stilgenbauer
ASH 2015: Ibrutinib as first-line treatment for chronic lymphocytic leukaemia ( Prof John Gribben and Prof Stilgenbauer )
6 Dec 2015
Cancer Core Europe: what has been achieved one year on?
Prof Alexander Eggermont and Prof Julio Celis
Cancer Core Europe: what has been achieved one year on? ( Prof Alexander Eggermont and Prof Julio Celis )
2 Dec 2015
Highlights of Cancer Prevention Europe
Dr Chris Wild - International Agency for Research on Cancer (IARC), Lyon, France
Highlights of Cancer Prevention Europe ( Dr Chris Wild - International Agency for Research on Cancer (IARC), Lyon, France )
2 Dec 2015
Cancer Core Europe: one year on (full version)
Prof Alexander Eggermont - Gustave Roussy, Villejuf, France
Cancer Core Europe: one year on (full version) ( Prof Alexander Eggermont - Gustave Roussy, Villejuf, France )
2 Dec 2015
Cancer Prevention Europe
Dr Chris Wild - International Agency for Research on Cancer (IARC), Lyon, France
Cancer Prevention Europe ( Dr Chris Wild - International Agency for Research on Cancer (IARC), Lyon, France )
2 Dec 2015
Removing unknowing financial investments from the tobacco industry
Dr Bronwyn King - Tobacco Free Portfolios, Melbourne, Australia
Removing unknowing financial investments from the tobacco industry ( Dr Bronwyn King - Tobacco Free Portfolios, Melbourne, Australia )
27 Nov 2015
Creating 'a world community' for cancer prevention, diagnosis and treatment
Dr May Abdel-Wahab - IAEA Division of Human Health, Austria, Vienna
Creating 'a world community' for cancer prevention, diagnosis and treatment ( Dr May Abdel-Wahab - IAEA Division of Human Health, Austria, Vienna )
27 Nov 2015
<1...5253545556...71>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top